COVID-19 - Considerations for the paediatric rheumatologist

Area of Science:

• Virology
• Immunology
• Pediatrics

Background:

• The novel coronavirus, SARS-CoV-2, poses a global health threat, with adults frequently experiencing severe disease and complications.
• While children can contract and transmit SARS-CoV-2, they typically exhibit milder symptoms and lower mortality rates compared to adults.

Purpose of the Study:

• To explore the reasons behind the differential disease severity of SARS-CoV-2 infection between pediatric and adult populations.
• To evaluate the potential of existing immunosuppressive therapies in preventing severe COVID-19 complications in children.

Main Methods:

• Comparative analysis of clinical outcomes in pediatric versus adult SARS-CoV-2 patients.
• Review of immunological and virological factors influencing disease progression based on age.
• Literature review on the efficacy of immunosuppressive treatments in managing cytokine storms.

Main Results:

• Children demonstrate distinct virus containment and clearance mechanisms compared to adults.
• Age-specific environmental and host factors contribute to reduced inflammation and organ damage in pediatric cases.
• Uncontrolled immune responses, or "cytokine storms," are primary drivers of severe COVID-19 in adults.

Conclusions:

• Age-related differences in immune response and host factors significantly impact SARS-CoV-2 disease severity.
• Targeted immunosuppressive therapies, effective in adults by controlling cytokine storms, may offer a protective strategy for children against severe COVID-19 complications.